Opening of the Blood Brain Barrier to Antitumor Agents

Project: Research project

StatusFinished
Effective start/end date2/1/88 → 2/29/16

Funding

  • National Institutes of Health: $414,096.00
  • National Institutes of Health: $33,242.00
  • National Institutes of Health: $622,111.00
  • National Institutes of Health: $617,969.00
  • National Institutes of Health: $426,044.00
  • National Institutes of Health: $395,717.00
  • National Institutes of Health: $600,718.00
  • National Institutes of Health: $641,893.00
  • National Institutes of Health: $600,336.00
  • National Institutes of Health: $615,892.00
  • National Institutes of Health: $622,111.00
  • National Institutes of Health: $612,834.00
  • National Institutes of Health: $415,241.00
View all
View less

Fingerprint

Blood-Brain Barrier
Antineoplastic Agents
Drug Therapy
Brain Neoplasms
Sulfhydryl Compounds
Glutathione
Acetylcysteine
Central Nervous System
Neoplasms
Immunoconjugates
Medulloblastoma
Central Nervous System Neoplasms
Primitive Neuroectodermal Tumors
Neoplasm Metastasis
Pharmaceutical Preparations
Survival
Radiotherapy
Magnetic Resonance Imaging
National Institute of Neurological Disorders and Stroke
Central Nervous System Agents

ASJC

  • Medicine(all)
  • Neuroscience(all)